Dynavax Technologies Corporation
DVAX
$10.97
$0.090.83%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 27.92% | 32.75% | 31.17% | 25.85% | -27.85% |
| Total Other Revenue | 2.66% | -50.49% | -50.83% | -53.57% | -26.45% |
| Total Revenue | 26.73% | 26.66% | 24.76% | 19.36% | -27.79% |
| Cost of Revenue | 29.95% | 23.13% | 7.24% | -5.49% | -29.21% |
| Gross Profit | 25.10% | 28.56% | 37.29% | 38.98% | -27.05% |
| SG&A Expenses | 9.62% | 14.73% | 12.53% | 4.89% | 11.33% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 16.56% | 17.59% | 14.94% | 5.18% | -2.76% |
| Operating Income | 412.69% | 165.65% | 94.62% | 102.93% | -107.13% |
| Income Before Tax | -267.65% | -365.28% | -807.11% | 806.57% | -61.31% |
| Income Tax Expenses | -25.50% | 156.33% | 431.90% | 75.42% | 152.02% |
| Earnings from Continuing Operations | -311.94% | -407.00% | -751.37% | 527.44% | -66.50% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -311.94% | -407.00% | -751.37% | 527.44% | -66.50% |
| EBIT | 412.69% | 165.65% | 94.62% | 102.93% | -107.13% |
| EBITDA | 1,592.66% | 263.87% | 121.15% | 121.14% | -101.79% |
| EPS Basic | -310.46% | -419.55% | -783.24% | 510.39% | -67.40% |
| Normalized Basic EPS | 91.50% | 93.96% | 267.95% | 647.41% | -77.98% |
| EPS Diluted | -381.17% | -508.33% | -1,009.22% | 382.62% | -65.88% |
| Normalized Diluted EPS | 98.44% | 102.85% | 360.20% | 386.45% | -78.71% |
| Average Basic Shares Outstanding | -6.17% | -3.12% | -0.45% | 1.03% | 1.66% |
| Average Diluted Shares Outstanding | -3.50% | -0.19% | 3.05% | 4.40% | -2.26% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |